Burudpakdee, C., Shah, A., Joish, V. N., Divers, C. H., & Yaldo, A. (2014). Budgetary Impact of Adding Riociguat to a US Health Plan for the Treatment of Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension. Am Health Drug Benefits.

Burudpakdee, Chakkarin, Anshul Shah, Vijay N. Joish, Christine H. Divers, and Avin Yaldo. "Budgetary Impact of Adding Riociguat to a US Health Plan for the Treatment of Patients With Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension." Am Health Drug Benefits 2014.

Burudpakdee, Chakkarin, et al. "Budgetary Impact of Adding Riociguat to a US Health Plan for the Treatment of Patients With Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension." Am Health Drug Benefits 2014.